Sep 2019

ANTG’S COO JAMES GASKELL ON THE ACT’S LEGALISATION OF CANNABIS FOR PERSONAL USE

With the ACT becoming the first Australian jurisdiction to legalise the possession and cultivation of cannabis for personal use, the often stigmatized ‘drug’ is once again being debated in the media. ANTG’s Chief Operating Officer, James Gaskell, joins 2SER Breakfast on 107.3 to discuss his thoughts on the recent legalisation, the conflict of state vs federal laws, and the medicinal cannabis industry in Australia and abroad. Listen to his interview here.

One of ANTG’s proprietary medicinal cannabis strains, EVE Cannabis Indica, has been listed on the Australian Register of Therapeutic Goods (ARTG). The ARTG is a reference of therapeutic goods that can lawfully be supplied in or exported from Australia.

READ MORE >

In conjunction with the HMRI and lead biomedical scientist Dr Matt Dun, we’re investigating the anticancer properties of our plant varieties. Dr Matt Dun shares his initial thoughts on the joint research project.

READ MORE >

What’s most important in business – purpose or profit? At ANTG we get to achieve both.

READ MORE >

We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.

LEARN ABOUT ANTG HERE >